Torbay Pharmaceuticals opened our 76,000 square foot manufacturing facility in 2017, the result of a £26m investment. Today our manufacturing site supports the needs of our customers in 20 countries around the world, supplying terminally sterilised injectable medicines, a range of non-sterile oral liquids and a wide range of ingredients for TPN compounding, both as Torbay Pharmaceutical licensed products and CMO/CDMO manufactured medicines.
Click on the link below to take a tour of our site. To find out more please contact us at customerservices@torbaypharma.com